Your browser doesn't support javascript.
loading
Clinical evaluation of switching from immediate-release to prolonged-release lithium in bipolar patients, poorly tolerant to lithium immediate-release treatment: A randomized clinical trial.
Pelacchi, Federica; Dell'Osso, Liliana; Bondi, Emi; Amore, Mario; Fagiolini, Andrea; Iazzetta, Paolo; Pierucci, Daniela; Gorini, Manuela; Quarchioni, Elisa; Comandini, Alessandro; Salvatori, Enrica; Cattaneo, Agnese; Pompili, Maurizio.
Afiliação
  • Pelacchi F; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Dell'Osso L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Bondi E; Psychiatric Service Diagnosis and Care, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Amore M; Institute of Rehabilitation and Care for Scientific Character San Martino Polyclinic Hospital, University Psychiatric Clinic, Genova, Italy.
  • Fagiolini A; Psychiatry, University-Hospital of Siena, Siena, Italy.
  • Iazzetta P; Functional Unit Mental Health Adults, San Giovanni di Dio Hospital, Orbetello-Grosseto, Italy.
  • Pierucci D; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Gorini M; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Quarchioni E; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Comandini A; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Salvatori E; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Cattaneo A; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Pompili M; Complex Operational Unit Psychiatry, Sant'Andrea University-Hospital, University of Rome La Sapienza, Rome, Italy.
Brain Behav ; 12(3): e2485, 2022 03.
Article em En | MEDLINE | ID: mdl-35137572
AIM: The effect of switching from lithium immediate release (Li-IR) to lithium prolonged release (Li-PR) on lithium-induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udvalg for Kliniske Undersøgelser [UKU] rating scale) despite optimal lithium titration. METHODS: The primary endpoint was the evaluation of tremor by means of the UKU scale after 1 week of treatment. Secondary endpoints included manic Young Mania Rating Scale (YMRS) and depressive symptoms (Montgomery-Asberg Depression Rating Scale), a global assessment of the patient's status (Clinical Global Impression), polyuria/polydipsia (UKU item 3.8) and patient-reported outcomes. RESULTS: Owing to difficulties in including suitable patients the enrollment phase was closed when 73 patients were randomized. Notwithstanding the lower number of patients, in the modified intention-to-treat population (n = 70) the primary endpoint was statistically significant: tremor improved after 1 week in 62.9% in Li-PR group against 20.0% of patients in Li-IR group (p = .0006; two-tailed Fisher's exact test). The difference remained statistically significant after 4 (p = .0031) and 12 weeks (p = .0128). The same analysis performed in the PP population confirmed these results. Among the secondary endpoints, only the factor convenience of the treatment satisfaction questionnaire showed a statistically significant difference between groups. There were no apparent differences in the safety profile of the two formulations. CONCLUSIONS: This study is the first comparative documentation of a potential benefit of the prolonged-release formulation in reducing the symptom tremor, a well-known adverse effect of lithium therapy. Indeed, the study results should be interpreted taking into account the sample size lower than planned.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Lítio Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Brain Behav Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Lítio Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Brain Behav Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália